COMMUNIQUÉS West-GlobeNewswire

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

05/02/2018 - 22:01

MALVERN, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]

Nuvectra™ Announces Closing of Follow-On Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

05/02/2018 - 22:01

PLANO, Texas, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today the closing of its underwritten follow-on public offering of 3,248,750 [...]

Bio-Path Holdings to Present at the BIO CEO & Investor Conference

05/02/2018 - 22:01

HOUSTON, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

Sol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

05/02/2018 - 22:01

NESS ZIONA, Israel, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (“Sol-Gel”) (NASDAQ: SLGL ), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and [...]

Emblem Announces Changes to Board of Directors

05/02/2018 - 22:00

TORONTO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (" Emblem " or the " Corporation ") announces that Mr. Gordon Fox, a director and founder of the Corporation, has tendered his resignation from [...]

GW Pharmaceuticals Announces the European Medicines Agency (EMA) Accepts Epidiolex® (cannabidiol) Marketing Authorization Application (MAA) for Review

05/02/2018 - 22:00

LONDON and CARLSBAD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and [...]

GW Pharmaceuticals plc Reports Fiscal First Quarter 2018 Financial Results and Operational Progress

05/02/2018 - 22:00

- Epidiolex ® (cannabidiol) NDA and MAA applications accepted for review – - NDA PDUFA goal date scheduled for June 27, 2018 - - Conference call today at 4:30 p.m. EST - LONDON and CARLSBAD, Calif., Feb. 05, 2018 (GLOBE [...]

Novo Nordisk A/S - Share repurchase programme

05/02/2018 - 20:48

Bagsværd, Denmark, 5 February 2018 - As part of the up to DKK 14 billion 2018 share repurchase programme, Novo Nordisk A/S has now initiated a new share repurchase programme for an amount of up to DKK 2.5 billion in [...]

BLVD Centers Announces Date and Time for End Of Quarter Update Conference Call

05/02/2018 - 20:43

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (TSXV:CXV), a leading company in the United [...]

Novo Nordisk A/S purchases B shares worth DKK 954 million from Novo Holdings A/S under the 2018 share repurchase programme

05/02/2018 - 20:31

Bagsværd, Denmark, 5 February 2018 - Novo Nordisk A/S has today entered into an agreement to purchase 3,087,410 B shares (nominal DKK 0.20) of a value of DKK 954 million from Novo Holdings A/S. This transaction is part [...]

Adventist Health Receives “A” Rating; Positive Outlook From Fitch Ratings

05/02/2018 - 20:18

ROSEVILLE, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii—is pleased to announce it has [...]

Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017

05/02/2018 - 19:11

Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017 Curetis subsidiary Ares Genetics receives funding commitment from Austrian [...]

LIPSG Announces Two Major Appointments: Tommaso Addona, MD, FACS, appointed Chief of Plastic Surgery at St. Joseph Hospital, Bethpage Jerry W. Chang, MD, appointed Chief of Plastic Surgery at NewYork-Presbyterian Queens

05/02/2018 - 19:00

GARDEN CITY, NY, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Long Island Plastic Surgical Group in Garden City is pleased to announce that two LIPSG surgeons were recently appointed Chief of Plastic Surgery at area hospitals. [...]

AspireAssist® Demonstrates Significant Weight Loss through Four Years with Strong Safety Profile

05/02/2018 - 18:15

KING OF PRUSSIA, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc., a commercial-stage medical device company, announced today the publication of 201-patient, multi-center post-market European registry [...]

Sanofi: Disclosure of trading in own shares

05/02/2018 - 17:46

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/ce99ad50-5d59-4896-8726-188fc74e598c

Sanofi : Déclaration des transactions sur actions propres

05/02/2018 - 17:46

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/5d94669a-e3c0-4d93-b256-600b9ce513b7

Nymox Announces US NDA for Fexapotide for BPH

05/02/2018 - 17:15

HASBROUCK HEIGHTS, N.J., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) announced today that the Company will submit a New Drug Application (NDA) for Fexapotide Triflutate for the [...]

Capricor Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Duchenne Muscular Dystrophy Therapy

05/02/2018 - 17:11

LOS ANGELES, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced that the U.S. Food and Drug Administration (FDA) has granted CAP-1002, its lead investigational cell therapy for the [...]

Ossur Hf : Transactions in relation to share buyback program

05/02/2018 - 17:01

Announcement from Össur hf. No. 7/2018 Reykjavík, 05 February 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]